Zestra
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
228 Park Ave S Pmb 300, New York City, N...Phone Number
(646) 569-9167Website
www.zestra.comRevenue
$7.6 MillionIndustry
About Zestra
Zestra Org Chart
Is Zestra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Zestra recently announced quarterly report
Check out if Zestra is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zestra
Check if Zestra has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Zestra has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Zestra had a recent Job posting/layoffs
Zestra, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Zestra launches new products
Recommended Actions
Find VP level buyers at Zestra
Find 2 more new buyers
Compare Similar Companies to Zestra
Compare insights from companies similar to Zestra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zestra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zestra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zestra.
Zestra Tech Stack
A closer look at the technologies used by Zestra
Zestra News & Media
Innovus Pharma Reports Another New Quarterly Revenue Record of Approximately $7.4 Million for the Third Quarter 2018 and $19.2 Million for the First Nine Months of 2018
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, announced today its reported results for the third quarter 2018. Notable Highlights from the Third Quarter of 2018 and Recent Developments Revenues of approximately $7.4 million,Innovus Pharma Announces Three Regulatory Filings with Health Canada for Its Products: Xyralid® Suppositories, Beyond Human® Testosterone and RecalMax™
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced the filing by it for regulatory approval in Canada for its (1) Xyralid® Suppositories drug for the relief of hemorrhoidal swelling, (2) Beyond Huma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zestra
Zestra, founded in 1996, is a pharmaceutical manufacturer that produces a patented blend of botanical oils and extracts designed to enhance female arousal. The company's products are backed by scientific research and are recommended by healthcare professionals. Zestra focuses on developing solutions that support women's sexual wellness and satisfac... Read More